The number of successful API (Application Programming Interface) calls made by third-party providers (TPPs) using ASPSP (Account Servicing Payment Service Providers) open banking APIs in the United Kingdom increased significantly over a six-year period. As of June 2018, there were approximately *** million monthly API calls. By February 2025, this figure had grown to over *** billion successful monthly calls, representing a substantial increase in open banking adoption and usage.

The United Kingdom Active Pharmaceutical Ingredients (API) Market is Segmented by Business Mode (Captive API and Merchant API), Synthesis Type (Synthetic and Biotech), Drug Type (Generic and Branded), and Application (Cardiology, Oncology, Pulmonology, Neurology, Orthopedic, Ophthalmology, and Other Applications). The report offers the value (in USD billion) for the above segments.

Dive into the UK market with Success.ai’s UK B2B Data API. Access 10M+ UK professionals and businesses with firmographic, contact, and financial data. Ideal for B2B marketers and sales teams targeting specific segments. Continuously updated, accurate, and cost-effective.

The United Kingdom Active Pharmaceutical Ingredients (API) market is experiencing robust growth, projected to expand significantly between 2025 and 2033. The 6.30% CAGR indicates a healthy and sustained demand driven by several key factors. The increasing prevalence of chronic diseases like cardiovascular conditions, cancer, and respiratory illnesses fuels the need for a wide range of pharmaceuticals, directly impacting API demand. Technological advancements in drug synthesis, particularly in synthetic and biotechnological approaches, are also contributing to market expansion. The market is segmented by business mode (captive and merchant APIs), synthesis type (synthetic and biotech), drug type (generic and branded), and application (cardiology, oncology, pulmonology, neurology, orthopedic, ophthalmology, and others). The dominance of specific segments will likely shift over the forecast period, with biotech APIs and APIs for treating chronic illnesses potentially experiencing above-average growth rates. Furthermore, the presence of established pharmaceutical giants like Pfizer, Novartis, and others, alongside emerging players, creates a competitive landscape that drives innovation and efficiency within the UK API market. Government regulations and initiatives focused on healthcare infrastructure and pharmaceutical research and development are expected to further support market growth. The competitive landscape is characterized by a mix of multinational pharmaceutical companies and domestic players. Large pharmaceutical companies often have captive API production facilities, while merchant API suppliers serve a broader range of clients. The increasing focus on cost-effectiveness and the rising adoption of generic drugs are likely to influence market dynamics in favor of generic API segments. However, potential restraints include fluctuations in raw material prices, regulatory hurdles related to drug approvals, and potential supply chain disruptions. Despite these challenges, the overall outlook for the UK API market remains positive, driven by continuous innovation, a growing healthcare infrastructure, and a rising demand for pharmaceutical products. The market is expected to witness significant expansion across various application areas, especially in sectors with high disease prevalence. Strategic partnerships and mergers and acquisitions are expected to shape the market in the coming years. Recent developments include: August 2022: Piramal Pharma Solutions expanded its Antibody-Drug Conjugate (ADC) capabilities at its Grangemouth facility in Scotland. The company invested EUR 55 million (USD 58.3 million) in the new Active Pharmaceutical Ingredient (API) infrastructure at its Morpeth facility in England., March 2022: Sterling Pharma acquired Novartis' Ringaskiddy campus near Cork, Ireland, to boost its capabilities in active pharmaceutical ingredients (APIs).. Key drivers for this market are: Increasing Prevalence of Infectious, Genetic, Cardiovascular, and Other Chronic Disorders, Increasing Adoption of Biologicals and Biosimilars; Rising Prevalence of Cancer and Increasing Sophistication in Oncology Drug Research. Potential restraints include: Increasing Prevalence of Infectious, Genetic, Cardiovascular, and Other Chronic Disorders, Increasing Adoption of Biologicals and Biosimilars; Rising Prevalence of Cancer and Increasing Sophistication in Oncology Drug Research. Notable trends are: Oncology Segment Expects to Register a High CAGR.

Our European Point of Interest (POI) data supports various location intelligence projects and facilitates the development of precise mapping and navigation tools, location analysis, address validation, and much more. Gain access to highly accurate, clean, and EU scaled POI data featuring over 2.3 million verified locations across the UK. We have been providing this data to companies worldwide for 30 years.

• Develop mapping and navigation tools and software.
• Identify new areas and locations suitable for business development.
• Analyze the presence of competitors and nearby populations.
• Optimize routes to enhance delivery efficiency.
• Evaluate property values based on nearby infrastructure.
• Support disaster management by identifying high-risk areas.
• Promote your products and services using geotargeting strategies.

Our use cases demonstrate how our data has been beneficial and helped our customers in several key areas: 1. Gaining a Competitive Edge: Utilize point of interest (POI) data to analyze competitors, identify high-opportunity areas, and attract more customers. 2. Enhancing Customer Journeys: Leverage location intelligence to provide personalized, real-time recommendations that boost customer engagement. 3. Optimizing Store Expansion: Select the most profitable locations by analyzing foot traffic, demographics, and competitor insights. 4. Streamlining Deliveries: Improve fulfillment accuracy through address validation, reducing failed shipments and increasing customer satisfaction. 5. Driving Smarter Campaigns: Use geospatial insights to effectively target the right audiences, enhance outreach, and maximize campaign impact.

The roadworks service (as know as ‘Street Manager’) provides data for England on every:

utility street work local highway authority road work

This data is added by utility companies and highway authorities, which requires separate registration, and is freely available via an API (Application Programming Interface).

You need to create an account to access the roadworks API service.

The number of successful payment initiations made by third party providers (TPPs) in the United Kingdom using account providers' (ASPSPs) open banking APIs grew sharply between January 2022 and February 2025. In February 2025, the number of successful payments was over 20 million.

This method returns the closest schools based on the specified criteria.

The dataset comprises multiple source datasets published by the Department for Education, and it is updated as soon as relevant datasets become available.

The MOT history API gives authorised third-party organisations a way to access MOT test history information for vehicles.

The information includes:

MOT test date MOT expiry date test result mileage reading MOT test number reasons for failure and advisory notices first MOT due date for new vehicles vehicle ID vehicle registration date vehicle manufacturing date cylinder capacity of the engine

Complete an application form giving details of your organisation and your intended use of the API: https://www.smartsurvey.co.uk/s/MOT_History_TradeAPI_Access_and_Support?

If your application is approved you will be given an API key that will let you access the MOT history data.

The British Geological Survey has one of the largest databases in the world on the production and trade of minerals. The dataset contains annual production statistics by mass for more than 70 mineral commodities covering the majority of economically important and internationally-traded minerals, metals and mineral-based materials. For each commodity the annual production statistics are recorded for individual countries, grouped by continent. Import and export statistics are also available for years up to 2002. Maintenance of the database is funded by the Science Budget and output is used by government, private industry and others in support of policy, economic analysis and commercial strategy. As far as possible the production data are compiled from primary, official sources. Quality assurance is maintained by participation in such groups as the International Consultative Group on Non-ferrous Metal Statistics. Individual commodity and country tables are available for sale on request.

HitHorizons UK B2B Data gives access to aggregated company data on 80M+ companies from the whole of Europe and beyond.

Company registration data: company name national identifier and its type registered address: street, postal code, city, state / province, country business activity: SIC code, local activity code with classification system year of establishment company type location type

Sales and number of employees data: sales in EUR, USD and local currency (with local currency code) total number of employees sales and number of employees accuracy local number of employees (in case of multiple branches) companies’ sales and number of employees market position compared to other companies in a country / industry / region

Industry data: size of the whole industry size of all companies operating within a particular SIC code benchmarking within a particular country or industry regional benchmarking (EU 27, state / province)

Contact details: company website company email domain (without person’s name)

Invoicing details available for selected countries: company name company address company VAT number.

This record contains data on the performance against service standards in relation to: performance against service standards in relation to replies to MP letters; outstanding out of service standard MP letters; performance against service standard for customer complaints, The number of calls to Hampshire's Sky Customer Service Centre. Includes data previously published in UKBA percentage of complaints responded to within service standards. Published by Hampshire County Council. *Licensed under [Open Government Licence] Open Government Licence. Openness rating: Open Data *Certificate: Raw Level Provided by: http://www.followthesteps.net/sky-contact-phone-number/ & http://www.faqtory.co/sky/ The information on this page (the dataset metadata) is also available in JSON format. API: /api/2/rest/package/uk-visas-immigration-customer-service-standards Read more about this site's CKAN API » http://data.gov.uk/data/api

This layer of the GeoIndex shows the location of available 1:10000 scale digital geological maps within Great Britain. The Digital Geological Map of Great Britain project (DiGMapGB) has prepared 1:625 000, 1:250 000 and 1:50 000 scale datasets for England, Wales and Scotland. The datasets themselves are available as vector data in a variety of formats in which they are structured into themes primarily for use in geographical information systems (GIS) where they can be integrated with other types of spatial data for analysis and problem solving in many earth-science-related issues. The DiGMapGB-10 dataset is as yet incomplete, current work is concentrated on extending the geographical cover, especially to cover high priority urban areas.

United Kingdom PC: Uses: sa: API: PI: Interest data was reported at 6,632.000 GBP mn in Mar 2018. This records an increase from the previous number of 6,368.000 GBP mn for Dec 2017. United Kingdom PC: Uses: sa: API: PI: Interest data is updated quarterly, averaging 7,130.000 GBP mn from Mar 1987 (Median) to Mar 2018, with 125 observations. The data reached an all-time high of 17,493.000 GBP mn in Mar 2008 and a record low of 1,776.000 GBP mn in Jun 1987. United Kingdom PC: Uses: sa: API: PI: Interest data remains active status in CEIC and is reported by Office for National Statistics. The data is categorized under Global Database’s UK – Table UK.AB034: ESA10: Resources and Uses: Private Non Financial Corporations: Primary Income.

TfL Live bus arrivals (released in October 2011), is the largest real-time bus arrival information system in the world. It allows customers to view live arrival information for the 19,000 bus stops in London via web, mobile web and SMS.

This API gives registered developers access to a scalable feed of the same real-time data used by the online Live bus arrival service.

Note: Using unsupported channels to source the data severely affects TFL's ability to support customers using the website during peak hours. It also contravenes the terms of use. TFL are unable to endorse or promote individual apps based on the feed, as part of this process.

To register for the API, and for the terms and conditions, visit the TfL Developers’ Area.

Some ideas

Apps developers can add this data to their travel tools:

- The 'Bus stops near you' location services can be refined using device-optimised applications

- Use the data to develop apps for visually impaired passengers

- Allow passengers to view the predicted arrival times (for the next 30 minutes) for a chosen bus route

- Venue owners could include their bus stop code with their listing details, allowing customers to easily find nearby bus stops

This method returns total crime rates, crime rates by crime types, area ratings by total crime, and area ratings by crime type for small areas (Lower Layer Super Output Areas, or LSOAs) and Local Authority Districts (LADs). The results are determined by the inclusion of the submitted postcode/coordinates/UPRN within the corresponding LSOA or LAD.

All figures are annual (for the last 12 months).

The crime rates are calculated per 1,000 resident population derived from the census 2021.

The dataset is updated on a monthly basis, with a 3-month lag between the current date and the most recent data.

The UK Active Pharmaceutical Ingredients (API) Market size was valued at USD 9.8 Billion in 2024 and is projected to reach USD 16.3 Billion by 2032, growing at a CAGR of 6.5% from 2026 to 2032.Key Market DriversGrowing Pharmaceutical R&D Investment: The UK has experienced substantial growth in pharmaceutical research and development investment, driving demand for novel and high-quality APIs. This investment trend supports the development of innovative drugs and strengthens the UK's position as a leading pharmaceutical hub. According to the Association of the British Pharmaceutical Industry (ABPI), the UK pharmaceutical sector invested USD 5.9 billion in R&D in 2023, representing a 17% increase from 2020 levels. The UK Office for Life Sciences reported that pharmaceutical companies initiated over 1,600 clinical trials in the UK in 2023, requiring specialized API production capabilities.Expanding Biosimilars and Biologics Production: The UK API is experiencing significant growth due to increasing focus on biologics and biosimilar manufacturing capabilities. This shift reflects the global trend toward biopharmaceuticals and positions the UK as a key player in advanced API production. The UK BioIndustry Association (BIA) reported that biologics manufacturing capacity in the UK expanded by 35% between 2021-2023, with over USD 1.56 billion invested in new biomanufacturing facilities.

Access Success.ai's 28M verified company profiles featuring comprehensive B2B contact data across all industries. With API integration, seamlessly incorporate up-to-date company data into your systems aligned to your needs, ensuring the most reliable information at the best price worldwide.

This method returns Census 2021 estimates on the number of households in England and Wales.

The estimates are as at Census Day, 21 March 2021.